ALVR Shareholders Who Lost Money Should Contact Robbins LLP for Information About the AlloVir, Inc. Class Action
10 févr. 2024 00h49 HE
|
Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
BNTX INVESTOR NEWS: Shareholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Against BioNTech SE
06 févr. 2024 00h36 HE
|
Robbins LLP
BioNTech SE (BNTX) Allegedly Misled Investors Regarding its Business Prospects
EVVTY Class Action Alert: Robbins LLP Reminds Investors of Evolution AB (publ) Class Action
01 févr. 2024 17h50 HE
|
Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
AlloVir, Inc. (ALVR) Stockholder News: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in AlloVir, Inc. Class Action
29 janv. 2024 19h45 HE
|
Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
BioVie Inc. (BIVI) Stockholder News: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in BioVie Inc. Class Action
29 janv. 2024 19h27 HE
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolution AB (publ) (EVVTY)
24 janv. 2024 20h25 HE
|
Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
ASRT Class Action Alert: Stockholders with Significant Losses in Assertion Holdings, Inc. Should Contact Robbins LLP for Information About the Class Action Lawsuit Against the Company
24 janv. 2024 20h23 HE
|
Robbins LLP
Assertio Holdings, Inc. (ASRT) Allegedly Misled Investors Regarding its Reliance on Indocin and Integration of Spectrum Pharmaceuticals, Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against BioVie Inc. (BIVI)
23 janv. 2024 15h24 HE
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against AlloVir, Inc. (ALVR)
22 janv. 2024 21h09 HE
|
Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
Dada Nexus Limited (DADA) Investor Alert: Robbins LLP Reminds Shareholders of Class Action Against Dada Nexus Limited
22 janv. 2024 17h59 HE
|
Robbins LLP
Dada Nexus Limited (DADA) Allegedly Overstated its Revenues